John J. Doyle, Dr.P.H., M.P.H.
Practice Leader, Managed Markets, U.S., Quintiles Consulting
Dr. John Doyle leads the U.S. Managed Markets practice for Quintiles Consulting, focusing on helping life sciences companies maximize the commercial success of their products through market access strategy and evidence-based research. Service areas include pricing and reimbursement strategy, health economic and outcomes research evaluations, health technology assessments, and scenario planning.
John joins us from Analytica International, a health economics and market access consulting firm he co-founded and led as President. Prior to that, John directed the Oncology and Immunology Economics Research Group at Bristol-Myers Squibb. Over the past 15 years, Dr. Doyle has authored over 50 peer-reviewed publications, in a variety of therapeutic areas which a special focus in cardiology, oncology and ophthalmology. He has consulted global pharmaceutical and biotech firms on strategic concerns regarding product development, pricing, reimbursement, market valuation, and other commercialization issues. Dr. Doyle received a Bachelor of Science degree in Applied Economics with a concentration in the Life Sciences from Cornell University. He received a Master of Public Health degree and a Doctor of Public Health degree in Epidemiology from the Mailman School of Public Health at Columbia University. Dr. Doyle is on faculty in the Departments Epidemiology and Healthcare Policy & Management at Columbia University's Mailman School of Public Health, where he teaches courses in pharmacoeconomics and pharmacoepidemiology.
